Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: Comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization

International Journal of Radiation Oncology Biology Physics

Volumn 64, Issue 5, 2006, Pages 1360-1366

  Akimoto, Tetsuo ^a   Katoh, Hiroyuki ^a   Kitamoto, Yoshizumi ^a   Shirai, Katsuyuki ^a   Shioya, Mariko ^a   Nakano, Takashi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Acute toxicity; High dose rate brachytherapy; Hypofractionation; Inverse optimization; Prostate cancer

Indexed keywords

DOSIMETRY; OPTIMIZATION; PARAMETER ESTIMATION; TOXICITY; TUMORS;

ACUTE TOXICITY; HIGH-DOSE-RATE BRACHYTHERAPY; HYPOFRACTIONATION; INVERSE OPTIMIZATION; PROSTATE CANCER;

RADIOTHERAPY;

ACUTE TOXICITY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; GEOMETRY; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; IRIDIUM RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL; RECTUM; URETHRA; UROGENITAL SYSTEM;

EID: 33645341440     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.10.005     Document Type: Article

References (23)

1. A.A. Martinez, L.L. Kestin, J.S. Stromberg Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer The William Beaumont phase II dose-escalating trial Int J Radiat Oncol Biol Phys 47 2000 343 352
2. A.C. Pellizzon, W. Nadalin, J.V. Salvajoli Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer Radiother Oncol 66 2003 167 172
3. J. Hiratsuka, Y. Jo, K. Yoshida Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer Int J Radiat Oncol Biol Phys 59 2004 684 690
4. R.M. Galalae, A. Martinez, T. Mate Long-term outcome by risk factors using conformal high-dose-rate brachytherapy (HDR-BT) boost with or without neoadjuvant androgen suppression for localized prostate cancer Int J Radiat Oncol Biol Phys 58 2004 1048 1055
5. S.J. Damore, A.M. Syed, A.A. Puthawala Needle displacement during HDR brachytherapy in the treatment of prostate cancer Int J Radiat Oncol Biol Phys 46 2000 1205 1211
6. T. Akimoto, K. Ito, J. Saitoh Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity Int J Radiat Oncol Biol Phys 63 2005 463 471
7. 200 parameters Australas Radiol 46 2002 384 389
8. I.K. Kolkman-Deurloo, X.G. Deleye, P.P. Jansen Anatomy based inverse planning in HDR prostate brachytherapy Radiother Oncol 73 2004 73 77
9. I.C. Hsu, E. Lessard, V. Weinberg Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy Brachytherapy 3 2004 147 152
10. B. Lachance, D. Beliveau-Nadeau, E. Lessard Early clinical experience with anatomy-based inverse planning dose optimization for high-dose-rate boost of the prostate Int J Radiat Oncol Biol Phys 54 2002 86 100
11. T. Akimoto, Y. Kitamoto, H. Niibe External beam radiation therapy for clinically node negative localized hormone refractory prostate cancer Impact of the pretreatment PSA value on radiotherapeutic outcomes Int J Radiat Oncol Biol Phys 59 2004 372 379
12. T. Akimoto, H. Muramatsu, T. Niibe Rectal bleeding after hypofractionated radiotherapy for prostate cancer Correlation between clinical and dosimetric parameters and the incidence of grade 2 or higher rectal bleeding Int J Radiat Oncol Biol Phys 60 2004 1033 1039
13. S. Ng, N. Gupta A simple method of obtaining equivalent doses for use in HDR brachytherapy Int J Radiat Oncol Biol Phys 46 2000 507 513
14. D. Baltas, C. Kolotas, K. Geramani A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy Int J Radiat Oncol Biol Phys 40 1998 515 524
15. T. Major, C. Polgar, A. Somogyi Evaluation of the dose uniformity for double-plane high dose rate interstitial breast implants with the use of dose reference points and dose non-uniformity ratio Radiother Oncol 54 2000 213 220
16. 192Ir interstitial breast implants Med Phys 15 1988 104 107
17. J.D. Cox, J. Stetz, T.F. Pajak Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1995 1341 1346
18. T. Akimoto, H. Katoh, S. Noda Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity Int J Radiat Oncol Biol Phys 63 2005 472 478
19. J. Fowler, R. Chappell, M. Ritter Is alpha/beta for prostate tumors really low? Int J Radiat Oncol Biol Phys 50 2001 1021 1031
20. D.J. Brenner, A.A. Martinez, G.K. Edmundson Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue Int J Radiat Oncol Biol Phys 52 2002 6 13
21. A.A. Martinez, G. Gustafson, J. Gonzalez Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer Int J Radiat Oncol Biol Phys 53 2002 316 327
22. J.E. Livsey, R.A. Cowan, J.P. Wylie Hypofractionated conformal radiotherapy in carcinoma of the prostate Five-year outcome analysis Int J Radiat Oncol Biol Phys 57 2003 1254 1259
23. M.J. Zelefsky, Z. Fuks, M. Hunt High-dose intensity modulated radiation therapy for prostate cancer Early toxicity and biochemical outcome in 772 patients Int J Radiat Oncol Biol Phys 53 2002 1111 1116